These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30302289)

  • 21. Neutron structure of human carbonic anhydrase II in complex with methazolamide: mapping the solvent and hydrogen-bonding patterns of an effective clinical drug.
    Aggarwal M; Kovalevsky AY; Velazquez H; Fisher SZ; Smith JC; McKenna R
    IUCrJ; 2016 Sep; 3(Pt 5):319-325. PubMed ID: 28461893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
    Aggarwal M; McKenna R
    Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design.
    Linkuvienė V; Zubrienė A; Manakova E; Petrauskas V; Baranauskienė L; Zakšauskas A; Smirnov A; Gražulis S; Ladbury JE; Matulis D
    Q Rev Biophys; 2018 Jan; 51():e10. PubMed ID: 30912486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon Dioxide "Trapped" in a β-Carbonic Anhydrase.
    Aggarwal M; Chua TK; Pinard MA; Szebenyi DM; McKenna R
    Biochemistry; 2015 Nov; 54(43):6631-8. PubMed ID: 26457866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using neutron crystallography to elucidate the basis of selective inhibition of carbonic anhydrase by saccharin and a derivative.
    Koruza K; Mahon BP; Blakeley MP; Ostermann A; Schrader TE; McKenna R; Knecht W; Fisher SZ
    J Struct Biol; 2019 Feb; 205(2):147-154. PubMed ID: 30639924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metal binding functions in the design of carbonic anhydrase inhibitors.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Curr Top Med Chem; 2007; 7(9):835-48. PubMed ID: 17504128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, function and applications of carbonic anhydrase isozymes.
    Imtaiyaz Hassan M; Shajee B; Waheed A; Ahmad F; Sly WS
    Bioorg Med Chem; 2013 Mar; 21(6):1570-82. PubMed ID: 22607884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversely
    Angeli A; Ferraroni M; Bonardi A; Supuran CT; Nocentini A
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2178430. PubMed ID: 36798036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
    Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
    Pastorekova S; Parkkila S; Pastorek J; Supuran CT
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dioxygen, an unexpected carbonic anhydrase ligand.
    Ferraroni M; Gaspari R; Scozzafava A; Cavalli A; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):999-1005. PubMed ID: 29806484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
    Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
    J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tracking solvent and protein movement during CO2 release in carbonic anhydrase II crystals.
    Kim CU; Song H; Avvaru BS; Gruner SM; Park S; McKenna R
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5257-62. PubMed ID: 27114542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structures of two tetrameric β-carbonic anhydrases from the filamentous ascomycete Sordaria macrospora.
    Lehneck R; Neumann P; Vullo D; Elleuche S; Supuran CT; Ficner R; Pöggeler S
    FEBS J; 2014 Apr; 281(7):1759-72. PubMed ID: 24506675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity.
    Bhatt A; Mahon BP; Cruzeiro VW; Cornelio B; Laronze-Cochard M; Ceruso M; Sapi J; Rance GA; Khlobystov AN; Fontana A; Roitberg A; Supuran CT; McKenna R
    Chembiochem; 2017 Jan; 18(2):213-222. PubMed ID: 27860128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C.
    Mujumdar P; Teruya K; Tonissen KF; Vullo D; Supuran CT; Peat TS; Poulsen SA
    J Med Chem; 2016 Jun; 59(11):5462-70. PubMed ID: 27172398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of zinc binding functions for carbonic anhydrase inhibitors.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Curr Pharm Des; 2008; 14(7):615-21. PubMed ID: 18336306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based design of an intramolecular proton transfer site in murine carbonic anhydrase V.
    Heck RW; Boriack-Sjodin PA; Qian M; Tu C; Christianson DW; Laipis PJ; Silverman DN
    Biochemistry; 1996 Sep; 35(36):11605-11. PubMed ID: 8794740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrases as drug targets--an overview.
    Supuran CT
    Curr Top Med Chem; 2007; 7(9):825-33. PubMed ID: 17504127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.